Public health alert issued for chicken and bacon ranch wraps over listeria concerns
A public health alert has been issued for some ready-to-eat wraps amid concerns that the products may be contaminated with listeria.
The U.S. Department of Agriculture's (USDA) Food Safety and Inspection Service (FSIS) earlier this week issued the alert for Rachel's Food Corp. chicken and bacon ranch wraps sold in Connecticut, Massachusetts and New York.
A recall was not requested because the affected products are no longer available for purchase, according to the announcement.
"The problem was discovered when a state public health partner notified FSIS of a product sample that tested positive for listeria monocytogenes," the FSIS said.
The wraps were sold under the brand names Big Y Quick Easy Meals and Market 32 by Price Chopper.
Both items come in a 10-ounce clear plastic clamshell package with a sell-by date of May 7 and the lot code of 25122.
The wraps have the establishment number P34657 inside the USDA mark of inspection.
Mike Pepin, vice president of operations for Massachusetts-based Rachel's Food Corp., told Fox News Digital there is no immediate concern regarding the wraps since they are out of circulation.
"Listeria infection is an illness caused by bacteria that can spread through many foods," according to the Mayo Clinic.
For more Lifestyle articles, visit foxnews.com/lifestyle
No illnesses have been reported "due to consumption of these products," the FSIS said. The items were produced on May 2.
Although the wraps are no longer on the market, the FSIS is "concerned that some products may be in consumers' refrigerators," according to the announcement.
Anyone who has purchased the wraps is "urged not to consume them."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
3 hours ago
- Medscape
Fast Five Quiz: Opioid Use Disorder
Opioid use disorder (OUD) currently impacts approximately 16 million people worldwide. It is considered a significant public health issue, with experts noting a 'burden that is increasing' globally. As research into optimal management of OUD evolves, updates to clinical guidelines emphasize a more individualized approach to pharmacologic treatment, psychosocial support, and special considerations for specific patient populations, such as pregnant individuals. However, OUD remains a complex disease that comes with many serious health and legal concerns for both patients and clinicians. What do you know about OUD? Check your knowledge with this quick quiz. Despite pharmacologic treatment being known to be highly effective for treating OUD, a CDC report states that 30% of patients with OUD who require OUD treatment received only nonpharmacologic treatment. Further, 43% of patients did not perceive a need for OUD treatment at all. In this significant report, males aged 35-49 years were most likely to receive OUD treatment with medications, while females and younger and older adults had lower rates of access to pharmacologic interventions. The CDC concluded that engaging patients needing OUD treatment with pharmacologic interventions is 'essential.' Learn more about essential statistics for OUD. Data from a predictive-model study indicate that service setting was the strongest predictor for premature discontinuation of OUD treatment. The strength of this predictor declined with length of stay, becoming negligent after 365 days. Other system-level factors such as geographic region, primary source of payment for treatment, and referral source were also strong predictors of early discontinuation; individual factors such as age of first use, sex, and race were less predictive. Previous research cited by the study has also stressed the importance of reducing system-level barriers to care, and the updated federal guidance for opioid treatment programs have expanded access in several ways. Learn more about OUD guidance. Precipitated withdrawal can occur when transferring a patient from methadone to buprenorphine due to buprenorphine being only a partial opioid agonist; as such, the traditional method of transfer involves putting the patient in a controlled, moderate withdrawal state before initiating buprenorphine therapy. However, a novel dosing strategy called microinduction, which involves starting buprenorphine at submilligram doses (or 'low-dose induction'), and cross-tapering with methadone can prevent precipitated withdrawal. Additionally, this method is ideal for patients who want to switch from methadone to buprenorphine and those with chronic use of intravenous or intranasal fentanyl. A recent systematic review found that microinduction and traditional transfer methods had similar rates of successful induction of buprenorphine at 95.6%. Learn more about safe withdrawal practices for OUD. Both the CDC and the latest American Society of Addiction Medicine (ASAM) guidelines specifically state that pharmacotherapy for OUD should be offered as early as possible in pregnancy to prevent harms to both the patient and the fetus, noting that pharmacotherapy for OUD has been associated with improved maternal outcomes. ASAM specifically states, 'increasing the dose or split dosing is often required, especially in the third trimester.' Federal guidelines emphasize that pregnant individuals seeking treatment for OUD are considered a priority for enrollment in opioid treatment programs. Once receiving treatment, they do not generally recommended medically supervised withdrawal from pharmacotherapy for pregnant patients as it might harm the fetus and patient; further, ASAM guidelines state that patients who undergo medically supervised withdrawal are at an increased risk for 'return to opioid use.' However, if a patient decides to proceed with medically supervised withdrawal, ASAM guidelines suggest physicians provide education and resources regarding associated risks. The CDC also specifically recommends against abruptly discontinuing opioids during pregnancy, citing data and resources from the American College of Obstetricians and Gynecologists and the Substance Abuse and Mental Health Services Administration. Learn more about OUD. Federal guidelines specify that opioid treatment programs must conduct at least eight random drug tests per year on their patients. These tests must use FDA approved products that test for commonly abused substances that might affect patient safety, recovery, or adherence to OUD treatment. ASAM affirms this requirement, noting that many patients might need more frequent testing and that eight tests per year 'should be viewed as a minimum.' Learn more about drug testing in OUD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication.
Yahoo
4 hours ago
- Yahoo
2 items added to ‘Dirty Dozen' list of most pesticide-contaminated produce
The Environmental Working Group (EWG) added blackberries and potatoes to its 'Dirty Dozen' list of produce containing the most residue of potentially harmful pesticides. Blackberries and potatoes landed in spots No. 10 and No. 12, respectively, on the updated list released Wednesday. They were added based on new data from the U.S. Department of Agriculture (USDA), which tested blackberries for the first time in 2023. The USDA data found that 93 percent of blackberry samples had pesticide residues, with an average of four different pesticides per sample. More than half of blackberry samples contained residue of the pesticide cypermethrin — which the Environmental Protection Agency (EPA) classifies as a possible human carcinogen. Potatoes landed on the list after USDA released new data showing 90 percent of samples contained chlorpropham, a chemical banned in the European Union because of health concerns. The legacy produce still topped the 'Dirty Dozen' list. Spinach ranked No. 1, with more pesticide residue by weight than any other type of produce, and strawberries followed at No. 2. 'Kale, Collard, and Mustard Greens' collectively placed No. 3 — and EWG noted that more than half of kale samples were 'tainted' by a 'possibly cancer-causing pesticide.' The 'Dirty Dozen' list ranked grapes as No. 4, peaches as No. 5, cherries as No. 6, nectarines as No. 7, pears as No. 8, apples as No. 9, blackberries as No. 10, blueberries as No. 11 and potatoes as No. 12. The guide analyzed pesticide residue data from USDA tests of more than 53,000 samples of 47 fruits and vegetables, EWG said in a press release. The tests are conducted after the produce samples are washed, scrubbed or peeled, 'as is typical for each type of produce.' EWG said the pesticide residue remained on the produce, but washing fruits and vegetables 'remains an important step to reduce pesticide levels, dirt, and possible bacterial contamination.' EWG encourages consumers to buy organic produce if they do not want to avoid the 'Dirty Dozen' produce items. EWG also publishes a 'Clean Fifteen' list of produce with overall lower levels of toxicity. Pineapples led that list this year, followed by sweet corn (fresh and frozen), avocados, papayas and onion as the top five produce items. Nos. 6-15 included sweet peas (frozen), asparagus, cabbage, watermelon, cauliflower, bananas, mangoes, carrots, mushrooms, and kiwi. EWG said nearly 60 percent of conventionally grown produce on the 'Clean Fifteen' list had 'no detectable pesticide residues,' while more than 9 in 10 samples of produce on the 'Dirty Dozen' list contained residues of potentially harmful pesticides. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
CBS News
5 hours ago
- CBS News
Boston is the most expensive U.S. city to raise a child, study finds
Study says Boston is most expensive U.S. city to raise child Study says Boston is most expensive U.S. city to raise child Study says Boston is most expensive U.S. city to raise child A new report has ranked the Boston-Cambridge-Newton metro area as the most expensive city in the U.S. to raise a child. According to SmartAsset, the total annual cost of raising a kid in 2025 is $39,221, a price tag that may come as a shock to some, but not Daquan Thompson. "When my child was drinking formula, there was only one that didn't mess up his stomach and that was the most expensive one," Thompson said. He's been feeling the pinch for years. "Every jar was $60 to $70, and he went through the jars in two or three days," he said. The father of a 2-year-old son named Julien shares that even simple outings like trips to the Children's Museum and the Science Museum can add up quickly. "It does get costly just for an outing with the family," he said. "The science museum is probably $35 per person. The aquarium is around the same range." With a family of four, Thompson says one of those outings can easily top $100, "then you have to pay for parking," he adds. According to the personal finance site, the cost of raising a child in Boston has increased by 3.87% since last year. In 2024, the cost was $37,758. Joel Diaz, a nanny and former daycare teacher in Boston, isn't surprised by the increase. "It's very hard out here," he says. "And for those families paying tuition, it costs thousands of dollars to put their children into daycare every month, especially if you have multiple." Cost breakdown The study breaks down where Boston parents are spending their money: •Childcare: $23,800 •Housing: $5,297 •Food: $2,232 •Medical: $3,290 •Transportation: $2,996 •Civic: $647 •Other: $959 Looking at the rising costs, Thompson says "it's unfortunate," but finds small moments of relief when he and Julien can enjoy free activities, like visits to the park.
